Immune to Cancer: The CRI Blog
-
How a Day of Golf and Beer Raised Money for Cancer Immunotherapy Research
Birdies & Brews mixes beer and golf while raising funds for cancer immunotherapy research.
-
Bladder Cancer Awareness Month: 2022 Immunotherapy Research Updates
This Bladder Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…
-
Brain Cancer Awareness Month: 2022 Immunotherapy Research Updates
This Brain Cancer Awareness Month, discover new research, new treatments, and progress for a future immune to…
-
Melanoma Monday: 2022 Immunotherapy Research Updates
This Melanoma Monday, discover new research, new treatments, and progress for a future immune to melanoma.
-
The Many Fates of T Cells with CRI Lloyd J. Old STAR Enrico Lugli, PhD
CRI Lloyd J. Old STAR Enrico Lugli, PhD, is deciphering why some T cells have longevity and…
-
AACR 2022 Recap: T Cells Still On Top, But Make Room for Myeloid Cells
At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…
-
Head and Neck Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Head and Neck Cancer Awareness Month, discover the new research, new treatments, and progress…
-
Esophageal Cancer Awareness Month: 2022 Immunotherapy Research Updates
This April for Esophageal Cancer Awareness Month, discover the new research, new treatments, and progress for a…
-
Ira Mellman Receives 2022 AACR-CRI Lloyd J. Old Award in Cancer Immunology
Dr. Ira Mellman, a longtime member of the CRI Scientific Advisory Council, received CRI’s highest scientific career…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.